Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors.

COVID-19 RNA interference RNA structure SARS-CoV-2 antisense oligonucleotides antiviral strategies influenza A virus small molecules

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
08 Jan 2023
Historique:
received: 02 12 2022
revised: 28 12 2022
accepted: 29 12 2022
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic, whereas the influenza A virus (IAV) causes seasonal epidemics and occasional pandemics. Both viruses lead to widespread infection and death. SARS-CoV-2 and the influenza virus are RNA viruses. The SARS-CoV-2 genome is an approximately 30 kb, positive sense, 5' capped single-stranded RNA molecule. The influenza A virus genome possesses eight single-stranded negative-sense segments. The RNA secondary structure in the untranslated and coding regions is crucial in the viral replication cycle. The secondary structure within the RNA of SARS-CoV-2 and the influenza virus has been intensively studied. Because the whole of the SARS-CoV-2 and influenza virus replication cycles are dependent on RNA with no DNA intermediate, the RNA is a natural and promising target for the development of inhibitors. There are a lot of RNA-targeting strategies for regulating pathogenic RNA, such as small interfering RNA for RNA interference, antisense oligonucleotides, catalytic nucleic acids, and small molecules. In this review, we summarized the knowledge about the inhibition of SARS-CoV-2 and influenza A virus propagation by targeting their RNA secondary structure.

Identifiants

pubmed: 36674746
pii: ijms24021232
doi: 10.3390/ijms24021232
pmc: PMC9860923
pii:
doi:

Substances chimiques

RNA 63231-63-0
RNA, Viral 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Science Centre
ID : UMO-2020/39/B/NZ1/03054
Organisme : National Science Centre
ID : UMO-2021/41/B/NZ1/03819
Organisme : National Science Centre
ID : UMO-2020/39/D/NZ6/03267

Références

Annu Rev Virol. 2015 Nov;2(1):265-88
pubmed: 26958916
Sci Adv. 2021 Nov 26;7(48):eabl6096
pubmed: 34826236
J Virol. 2012 Apr;86(8):4631-43
pubmed: 22345457
RNA. 2011 Sep;17(9):1747-59
pubmed: 21799029
Mol Ther. 2021 Jul 7;29(7):2219-2226
pubmed: 33992805
Cell. 2021 Apr 1;184(7):1865-1883.e20
pubmed: 33636127
Sci Rep. 2022 Jan 10;12(1):310
pubmed: 35013354
Sci Rep. 2019 Mar 7;9(1):3801
pubmed: 30846846
J Virol. 2021 Jun 24;95(14):e0066321
pubmed: 33963053
RNA. 2011 Jun;17(6):991-1011
pubmed: 21536710
OMICS. 2009 Oct;13(5):421-30
pubmed: 19594376
Angew Chem Int Ed Engl. 2021 Jan 4;60(1):432-438
pubmed: 32939952
Curr Med Chem. 2009;16(28):3716-39
pubmed: 19747144
Front Biosci. 2008 May 01;13:4873-81
pubmed: 18508552
Nucleic Acids Res. 2013 Jul;41(12):6209-21
pubmed: 23620279
Nat Commun. 2021 Aug 25;12(1):5113
pubmed: 34433821
J Biol Chem. 2021 Dec;297(6):101245
pubmed: 34688660
Biochem J. 2016 Dec 1;473(23):4327-4348
pubmed: 27694388
Mol Cell Biol. 1999 Apr;19(4):2657-71
pubmed: 10082532
Nucleic Acids Res. 2020 Nov 18;48(20):11270-11283
pubmed: 33068416
Cell Res. 2021 Apr;31(4):395-403
pubmed: 33603116
RNA Biol. 2014;11(7):942-52
pubmed: 25180940
RNA Biol. 2021 Apr;18(4):447-456
pubmed: 32965173
J Antimicrob Chemother. 2021 Jan 19;76(2):413-417
pubmed: 33164048
Pathogens. 2020 Nov 15;9(11):
pubmed: 33203084
Int J Mol Sci. 2022 Feb 23;23(5):
pubmed: 35269600
J Virol. 2010 Sep;84(17):8849-60
pubmed: 20554777
PLoS One. 2012;7(6):e38323
pubmed: 22685560
Nat Rev Drug Discov. 2018 Aug;17(8):547-558
pubmed: 29977051
Arch Med Res. 2009 Nov;40(8):669-72
pubmed: 20304254
J Virol. 1999 Oct;73(10):8349-55
pubmed: 10482585
Mol Biol Evol. 2021 Jan 23;38(2):575-588
pubmed: 32986832
Virus Evol. 2019 Aug 21;5(2):vez034
pubmed: 31456885
Vaccine. 2002 Aug 19;20(25-26):3068-87
pubmed: 12163258
J Virol. 2011 Jun;85(11):5593-605
pubmed: 21430057
Science. 2021 Jun 18;372(6548):1306-1313
pubmed: 34029205
Front Microbiol. 2018 Mar 29;9:559
pubmed: 29651275
Proc Natl Acad Sci U S A. 2004 May 11;101(19):7287-92
pubmed: 15123812
RNA Biol. 2012 Nov;9(11):1305-10
pubmed: 23064116
Nat Microbiol. 2019 Nov;4(11):1781-1789
pubmed: 31332385
Nature. 2014 Dec 18;516(7531):355-60
pubmed: 25409142
Mol Ther Nucleic Acids. 2022 May 31;29:64-74
pubmed: 35784013
Nature. 2012 Sep 6;489(7414):101-8
pubmed: 22955620
Wiley Interdiscip Rev RNA. 2022 Jul;13(4):e1703
pubmed: 34842345
Viruses. 2019 Apr 29;11(5):
pubmed: 31035717
Nat Med. 2022 Sep;28(9):1944-1955
pubmed: 35982307
Pathogens. 2020 Nov 07;9(11):
pubmed: 33171815
Virus Res. 2017 Apr 15;234:103-117
pubmed: 28115197
Heliyon. 2020 Sep;6(9):e05007
pubmed: 32984620
Arch Virol. 2009;154(5):821-32
pubmed: 19370391
Nucleic Acids Res. 2007;35(2):371-89
pubmed: 17170000
ACS Cent Sci. 2020 Oct 28;6(10):1713-1721
pubmed: 33140033
Viruses. 2022 Feb 04;14(2):
pubmed: 35215915
PLoS Comput Biol. 2021 Jan 19;17(1):e1008603
pubmed: 33465066
Nature. 2009 Apr 16;458(7240):914-8
pubmed: 19194459
J Mol Biol. 2021 Jan 22;433(2):166725
pubmed: 33245961
Mol Ther Nucleic Acids. 2018 Mar 2;10:361-375
pubmed: 29499948
Pharmaceutics. 2021 Nov 26;13(12):
pubmed: 34959297
Angew Chem Int Ed Engl. 2021 Sep 27;60(40):21662-21667
pubmed: 34278671
Virus Res. 2015 Aug 3;206:120-33
pubmed: 25736566
Nat Commun. 2021 Jun 24;12(1):3917
pubmed: 34168138
PLoS One. 2016 Feb 05;11(2):e0148281
pubmed: 26848969
Nucleic Acids Res. 2001 Jan 15;29(2):464-78
pubmed: 11139617
Biochem Biophys Res Commun. 2008 Jan 11;365(2):369-74
pubmed: 17996729
Nucleic Acids Res. 2019 Jul 26;47(13):7003-7017
pubmed: 31053845
Vaccine. 2008 Sep 12;26 Suppl 4:D49-53
pubmed: 19230160
Nucleic Acid Ther. 2016 Oct;26(5):277-285
pubmed: 27463680
Nat Struct Mol Biol. 2021 Sep;28(9):747-754
pubmed: 34426697
J Biol Chem. 2020 Jul 31;295(31):10741-10748
pubmed: 32571880
Bioinformatics. 2007 Feb 1;23(3):272-6
pubmed: 17090581
Viruses. 2020 Dec 21;12(12):
pubmed: 33371200
PLoS One. 2015 Oct 21;10(10):e0141132
pubmed: 26488402
Cell Res. 2004 Dec;14(6):460-6
pubmed: 15625012
Nat Commun. 2021 Jul 20;12(1):4396
pubmed: 34285203
PLoS One. 2016 Jun 07;11(6):e0156906
pubmed: 27272307
Vaccine. 2003 May 1;21(16):1801-3
pubmed: 12686098
Yale J Biol Med. 2009 Dec;82(4):153-9
pubmed: 20027280
RNA. 2022 Apr;28(4):508-522
pubmed: 34983822
J Gen Virol. 2007 Jul;88(Pt 7):2003-2012
pubmed: 17554034
Nature. 2009 Apr 16;458(7240):909-13
pubmed: 19194458
Nucleic Acids Res. 2021 Apr 6;49(6):3092-3108
pubmed: 33693814
Nucleic Acids Res. 2020 Dec 16;48(22):12436-12452
pubmed: 33166999
Cells. 2020 May 20;9(5):
pubmed: 32443810
Science. 2005 Sep 2;309(5740):1519-24
pubmed: 16141061
Ann Saudi Med. 2010 Jan-Feb;30(1):1-10
pubmed: 20103951
Viruses. 2021 Mar 22;13(3):
pubmed: 33810157
Nat Rev Microbiol. 2015 Jan;13(1):28-41
pubmed: 25417656
Antivir Ther. 2008;13(1):109-14
pubmed: 18389905
Nat Commun. 2022 Aug 3;13(1):4503
pubmed: 35922434
Methods Mol Biol. 2020;2203:1-29
pubmed: 32833200
Biochemistry. 2015 Jun 2;54(21):3269-85
pubmed: 25909229
Mol Ther Nucleic Acids. 2020 Mar 6;19:627-642
pubmed: 31945726
Angew Chem Int Ed Engl. 2021 Aug 23;60(35):19191-19200
pubmed: 34161644
RNA. 2020 Aug;26(8):937-959
pubmed: 32398273
Bioconjug Chem. 2019 Mar 20;30(3):931-943
pubmed: 30721034
J Virol. 2011 Feb;85(4):1554-62
pubmed: 21123387
Proc Natl Acad Sci U S A. 2021 Jun 29;118(26):
pubmed: 34185680
Front Chem. 2021 Dec 23;9:802766
pubmed: 35004621
ACS Cent Sci. 2022 Feb 23;8(2):205-213
pubmed: 35233452
Tohoku J Exp Med. 2020;250(4):271-278
pubmed: 32321874
J Virol. 2020 Dec 2;:
pubmed: 33268519
Infect Genet Evol. 2020 Nov;85:104502
pubmed: 32798769
J Appl Microbiol. 2001 Oct;91(4):572-9
pubmed: 11576290
Mol Diagn Ther. 2011 Apr 1;15(2):63-81
pubmed: 21623644
J Virol. 1994 Jun;68(6):4092-6
pubmed: 8189550
PLoS One. 2020 Dec 31;15(12):e0244809
pubmed: 33382859
Annu Rev Biophys. 2013;42:217-39
pubmed: 23654304
Science. 2012 Dec 21;338(6114):1634-7
pubmed: 23180776
RNA Biol. 2016 Sep;13(9):883-94
pubmed: 27399914
Chem Commun (Camb). 2014 Jan 11;50(3):368-70
pubmed: 24247110
Bioorg Med Chem. 2021 Sep 15;46:116356
pubmed: 34416512
Mol Cell. 2020 Dec 17;80(6):1067-1077.e5
pubmed: 33259809
Virology. 2010 May 25;401(1):29-41
pubmed: 20202661
Sci Rep. 2016 Dec 14;6:38892
pubmed: 27966593
ACS Biomater Sci Eng. 2022 Jul 11;8(7):3087-3106
pubmed: 35729709
Mol Cell. 2021 Feb 4;81(3):584-598.e5
pubmed: 33444546
Front Immunol. 2018 Jul 20;9:1581
pubmed: 30079062
NAR Genom Bioinform. 2021 May 22;3(2):lqab043
pubmed: 34046592
J Virol. 2019 Feb 5;93(4):
pubmed: 30463970
Virology. 2021 Feb;554:75-82
pubmed: 33387787
Meta Gene. 2021 Sep;29:100910
pubmed: 33996501
Heliyon. 2020 Aug;6(8):e04793
pubmed: 32869005
FEBS Lett. 2013 Apr 17;587(8):1206-14
pubmed: 23499938
Sci Rep. 2017 Nov 8;7(1):15041
pubmed: 29118447
Chem Biol Drug Des. 2015 Oct;86(4):663-73
pubmed: 25676805
Nat Commun. 2022 Mar 2;13(1):1128
pubmed: 35236847
PLoS One. 2013 Sep 02;8(9):e70615
pubmed: 24023714
Mol Cell Biol. 1991 Sep;11(9):4581-90
pubmed: 1875941
Nucleic Acids Res. 2020 Dec 16;48(22):12415-12435
pubmed: 33167030
Curr Opin Virol. 2022 Feb;52:123-134
pubmed: 34915287
Hum Vaccin. 2010 Oct;6(10):792-801
pubmed: 20935469
Emerg Microbes Infect. 2020 Dec;9(1):1407-1414
pubmed: 32543285
RNA Biol. 2017 Nov 2;14(11):1606-1616
pubmed: 28662365
J Virol. 1995 Jul;69(7):4012-9
pubmed: 7769659
J Drug Target. 2021 Apr;29(4):349-364
pubmed: 33210953
Biochem Biophys Res Commun. 2009 Dec 18;390(3):421-6
pubmed: 19755113
Biochemistry. 2014 Aug 19;53(32):5236-48
pubmed: 25026548
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
RNA. 2007 May;13(5):763-80
pubmed: 17353353
Virology. 2015 Jan 15;475:15-27
pubmed: 25462342

Auteurs

Izabela Szczesniak (I)

Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.

Agnieszka Baliga-Gil (A)

Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.

Aleksandra Jarmolowicz (A)

Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.

Marta Soszynska-Jozwiak (M)

Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.

Elzbieta Kierzek (E)

Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH